Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- Testing Diverse Groups Finds New Breast Cancer Genes (L Teras)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- High-Risk Genes and Screening (A Patel)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- Black Men and Breast Cancer (H Sung)
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Natural Killer Cells & TNBC (R. Chakrabarti)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Treatments Attack Cell Division (A Holland)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Time-Lapse Cell Movies (S Spencer)
- 3D Mini Breast Tumors May Help ID New Cancer Treatments
- AI Tool Improves Breast Cancer Prognosis Accuracy
- Exercise & Sitting Time (E. Rees-Punia)
- Cancer Risk Factors in LGBTQ Populations (B. Charlton)
- CPS-3 Disparities Studies
- Cancer Disparities in the US (F. Islami)
- Housing Assistance and Mammograms (H Lee)
- Clinical Trial Treatment Cost App (L Hamel)
- Podcasts, TheoryLab
- Patients Health Insurance Tool (M. Politi)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Better Survival Requires Better Insurance (J Zhao)
- Medicaid Eligibility Limits (J Zhao)
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- New Epigenetic Target (K Rai)
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Discovery of a New Biomarker Is the First Step to New Treatment (C. Maher)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
- Spatial Map Intestines (J Hickey)
- CRC Treatment Podcasts
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask What People Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
- Biomarkers May Improve Prediction (Y Wang)
- Kickstart NSCLCs Clinical Trials (L. Eichner)
- Mapping Mitochondria's “Dance” (D. Shackleford)
- E-Cig Use Ages 18 to 29 (P. Bandi)
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Jänne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
- CPS-II & CPS-3 Inform About Risks of Ovarian Cancer
- Machine Learning & Glowing Nanosensors (D Heller)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- New Gene Linked with Deadliest Type (C Han)
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Ovarian Cancer Special Section
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
Improving Quality of Life for Lung Cancer Survivors
Study leads to a clinical trial of virtual sessions to help people with early-stage lung cancer successfully transition from treatment to follow-up care.
The Challenge
For some people with cancer, the need for treatment and supportive care continues for a long time. Even when the goal of treatment is to cure the cancer, finishing treatment does not mean that a patient’s cancer experience is over. Depending on the type of cancer, patients will have a range of supportive care needs as they transition from active treatment to routine follow-up care (also known as surveillance care).
While there are studies describing what patients most need during this transition, people with lung cancer rarely are included in these quality-of-life (QoL) studies. Thus, their supportive care needs remain a grey area. Research to better understand those needs can inform cancer programs and providers to help patients set the stage for survivorship with coping strategies that address their specific concerns.
The Research
Massachusetts General Hospital recently funded a pilot study of a supportive care intervention for patients who have completed treatment for lung cancer. Results of this study were published in an abstract and presented at the 2021 American Society of Clinical Oncology Quality Care Symposium. American Cancer Society (ACS) did not fund the study, but three of the four abstract authors are current or previous ACS grantees: Lara Traeger, PhD, Joseph Greer, PhD, and Jennifer Temel, MD. (See information about their grants below.)
A primary goal of my research is to develop and evaluate the impact of supportive care interventions that are tailored to the needs of patients with cancer and their caregivers throughout their illness trajectory. I’m using innovative delivery modalities, including mobile apps, video tools, and telehealth, to make supportive care interventions accessible outside of the cancer clinic for patients and their caregivers. In this pilot study with my Massachusetts General Hospital colleagues, we tested the feasibility and acceptability of virtual visits for patients with lung cancer to help achieve their best possible quality of life after their treatments had ended.”
Jennifer Temel, MD
Massachusetts General Hospital in Boston
ACS Research Professor
The researchers interviewed patients about their quality of life after their lung cancer treatments had ended. Then, they used these findings to develop and refine a program to support survivors during the transition from treatment to follow-up care – ensuring that the program addressed the challenges and concerns that patients had described.
According to the findings from the study, after curative treatment for lung cancer, patients:
- Faced unexpected challenges in coping with residual symptoms
- Felt uncertain about their future health
- Experienced changes in access to social support
Patients who participated in the study said they valued the opportunity to validate their experiences, address current challenges, and cope with difficult emotions.
Although their feedback indicated that timing of the intervention (3 weeks after cancer treatments ended) and its content targeted the patients’ needs and concerns, results suggested that further refinement might enhance their use of new skills.
Jennifer Temel, MD, is an American Cancer Society Clinical Research Professor (grant term 9/1/2020 to 8/31/2025). Her grant project focuses on ensuring the delivery of high-quality care for patients with cancer.
Lara Traeger, PhD, had two grants (1/1/2011 to 12/31/2013 and 7/1/14 to 12/31/2019) related to depression and mental health in cancer patients that lead to a clinical trial of an intervention to help manage cancer pain.
Joseph Greer, PhD, had a grant (1/1/2013 to 12/31/2017) for studying web-based cognitive behavioral therapy for anxiety in patients with incurable cancer that also led to a clinical trial.
Why It Matters
This pilot study demonstrated the value of the program’s framework and virtual delivery—which supports scalability for survivors of lung cancer regardless of their location. The success of this pilot study helped lead to a clinical trial called The Transitions Project, led by Lara Traeger, PhD.